CILINITAB M 25

Description

CILINITAB M 25 Metoprolol Succinate 23.75 mg & Cilnidipine 10 mg Introduction to CILINITAB M 25 CILINITAB M 25 is a combination medication containing Metoprolol Succinate (23.75 mg) and Cilnidipine (10 mg), formulated to effectively manage hypertension (high blood pressure) and related cardiovascular conditions. This dual-action therapy combines the benefits of a beta-blocker (Metoprolol Succinate) and a calcium channel blocker (Cilnidipine) to provide comprehensive blood pressure control and enhance cardiovascular protection. CILINITAB M 25 is particularly beneficial for patients requiring multiple mechanisms to achieve optimal blood pressure levels and heart health. What are Metoprolol Succinate and Cilnidipine? Overview of Metoprolol Succinate Metoprolol Succinate is a beta-adrenergic blocker (beta-blocker) that works by blocking beta-1 receptors in the heart, leading to a reduction in heart rate and myocardial contractility. This action decreases the workload on the heart and helps lower blood pressure, making it an effective treatment for hypertension, angina, and heart failure. Overview of Cilnidipine Cilnidipine is a calcium channel blocker (CCB) that targets both L-type and N-type calcium channels. By inhibiting these channels, Cilnidipine relaxes blood vessels, reduces vascular resistance, and lowers blood pressure. The dual action on L-type and N-type calcium channels also provides additional benefits in terms of heart and renal protection. Benefits of CILINITAB M 25 Comprehensive Blood Pressure Control Dual Mechanism: By combining Metoprolol Succinate and Cilnidipine, CILINITAB M 25 addresses multiple pathways involved in blood pressure regulation, providing more effective control. Reduced Heart Rate and Vascular Resistance: Metoprolol reduces heart rate and myocardial contractility, while Cilnidipine relaxes and widens blood vessels, leading to a synergistic reduction in blood pressure. Cardiovascular Protection Heart Health: Effective blood pressure management reduces the risk of heart-related complications such as heart attacks, heart failure, and arrhythmias. Renal Protection: Cilnidipine’s action on N-type calcium channels offers additional benefits in protecting kidney function, especially in hypertensive patients with diabetes or renal impairment. Improved Quality of Life Symptom Relief: Effective blood pressure management can alleviate symptoms such as headaches, dizziness, and fatigue associated with hypertension. Long-Lasting Effect: The combination of Metoprolol Succinate and Cilnidipine provides sustained blood pressure control throughout the day. How to Use CILINITAB M 25 Dosage and Administration Recommended Dosage: The standard dose of CILINITAB M 25 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and medical condition. Administration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Guidelines for Optimal Use Consistency: For best results, take CILINITAB M 25 at the same time each day to maintain consistent blood levels. Monitoring: Regularly monitor your blood pressure and heart rate to ensure the medication is effectively controlling your condition. Follow your healthcare provider's instructions regarding blood pressure monitoring. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 https://www.sterisonline.com/product/cilinitab-m-25-133279